Cepheid

Call Directions Website

Cepheid Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility.

Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing "A Better Way" for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology, and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

10/20/2026

Innovation matters most when it reaches the people who need it. As we celebrate 30 years of Cepheid, our associates reflect on the role innovation has played in expanding access to diagnostics and helping improve patient care around the world.

Cepheid began in 1996 with a belief in a better way. Ten years later, the GeneXpert® system entered the clinical market ...
10/19/2026

Cepheid began in 1996 with a belief in a better way. Ten years later, the GeneXpert® system entered the clinical market and helped redefine what molecular diagnostics could be.

Today, we celebrate 20 years of GeneXpert innovation and the countless clinicians, laboratorians, and healthcare teams who have used fast, simple, and accessible testing to help improve patient care around the world. And we're just getting started. Always onward.

https://www.cepheid.com

We’re getting ready for Global Health Exhibition 2026 (GHE26) in Riyadh!Danaher Diagnostics and its operating companies ...
10/18/2026

We’re getting ready for Global Health Exhibition 2026 (GHE26) in Riyadh!

Danaher Diagnostics and its operating companies — Beckman Coulter Diagnostics, Cepheid, Leica Biosystems, and Radiometer— look forward to connecting with healthcare professionals and laboratory leaders to explore the future of diagnostics and healthcare innovation.

📍 Booth: H3 J20
📅 26–29 October 2026
📌 Riyadh Exhibition & Convention Center, Malham
✨ Attending GHE26? Visit our Innovation Suite to discover our latest solutions and connect with our experts.
👉 Innovation Suite registration:

We look forward to seeing you in Riyadh!

10/15/2026

For our associates, 30 years of Cepheid means something simple: making a positive impact on people's lives. From improving access to diagnostics to supporting better healthcare around the world, every contribution helps move us forward.

10/15/2026

What does the future of infectious disease diagnostics look like? At the 2025 EU Excellence Champions Club, laboratory experts shared insights on antimicrobial resistance, evolving testing strategies, and the growing role of molecular diagnostics in supporting confident clinical decisions.

Explore insights from experts on topics including:
https://ow.ly/9luq50ZXlpY

➡️ Early screening for drug-resistant threats
➡️ The ongoing challenge of C. difficile infections
➡️ Evolving prevention strategies for Group B Streptococcus
➡️ The importance of testing strategy in antimicrobial stewardship
➡️ Advances in mycobacterial diagnostics

Now, we're looking ahead to Stockholm in 2026, where the conversation continues.
📍 Stockholm, Sweden
📅 October 21-23, 2026

A fantastic experience at WCOG 2026! From engaging scientific discussions to building relationships with leading GI expe...
10/14/2026

A fantastic experience at WCOG 2026! From engaging scientific discussions to building relationships with leading GI experts, the congress provided an excellent platform to advance conversations around the future of GI diagnostics. Thank you to everyone who connected with us and contributed to these meaningful exchanges.

Click Here to learn more about Cepheid's molecular diagnostic solutions!
https://ow.ly/NThz50ZXiqy






IVD. In Vitro Diagnostic Medical Device. May not be available in all countries

Respiratory testing is not one-size-fits-all.In “Goldilocks Diagnostics: Finding the Right Respiratory Test for the Righ...
10/13/2026

Respiratory testing is not one-size-fits-all.

In “Goldilocks Diagnostics: Finding the Right Respiratory Test for the Right Patient,” we explore how diagnostic stewardship can help align respiratory testing with the patient, setting, and clinical question.

The timing is especially meaningful as Cepheid expands its respiratory testing portfolio with the U.S. launch of the Xpert® Respiratory Panel, a mid-plex option designed to detect 13 respiratory pathogens when broader insight may help inform care.

The goal is to choose the approach that is just right for the clinical question in front of you.

Read the article: https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2026/10/goldilocks-diagnostics-finding-the-right-respiratory-test-for-the-right-patient.html



IVD. In vitro diagnostic medical device. May not be available in all countries

10/13/2026

Innovation starts with a commitment to improve. Our associates describe 30 years of continuous improvement, empathy, and dedication to helping patients. These values continue to drive our work every day.

Join us on October 14 for “Timely Detection, Better Decisions: Transforming Respiratory Infection Management with PCR Di...
10/13/2026

Join us on October 14 for “Timely Detection, Better Decisions: Transforming Respiratory Infection Management with PCR Diagnostics.” In this APSR educational initiative, supported by Cepheid, renowned experts will discuss how diagnostic timing, accuracy, and scope can transform respiratory infection management and drive better clinical outcomes.

Don't miss this opportunity to gain expert insights into PCR diagnostics.

Register now: https://us02web.zoom.us/webinar/register/WN_LB7JPUfzQum77R2tiMRZJg #/registration

-19

Address

904 E Caribbean Drive
Sunnyvale, CA
94089

Alerts

Be the first to know and let us send you an email when Cepheid posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share